- Country: USA
- Summary: Technical Consulting Services and Data Analysis of Glucagon-Like Peptide-1 (Glp-1) Analogues as a Novel Pharmacotherapeutic Approach for Alcohol Use Disorder (Aud)
- UST Ref No: 86493632
- Deadline: 01 Aug 2023
- Financier: Self Financed
- Purchaser Ownership: Government
- Tender Value: Refer Document
- Notice Type: Tender
- Document Ref. No.: 75N95023Q00552SB
- Purchaser's Detail:Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details. Login to see full purchaser details.
- Description:
- Description
The National Institute on Drug Abuse - Intramural Research Branch (NIDA-IRP) Clinical Program is seeking Capability Statements from Small Business organizations to provide the Government support for technical consulting services and data analysis of Glucagon-like peptide-1 (GLP-1) analogues as a novel pharmacotherapeutic approach for alcohol use disorder (AUD).
This is a SOURCES SOUGHT NOTICE. This is NOT a solicitation for proposals, proposal abstracts, or quotations. The purpose of this notice is to obtain information regarding: (1) the availability and capability of qualified business sources; (2) the availability of capable Small Businesses; HUBZone Small Businesses; Service-Disabled, Veteran-Owned Small Businesses; 8(a) Small Businesses; Veteran-Owned Small Businesses; Woman-Owned Small Businesses; or Small Disadvantaged Businesses; and (3) their size classification relative to the North American Industry Classification System (NAICS) code for the proposed acquisition. Your responses to the information requested will assist the Government in determining the appropriate acquisition method, including whether a set-aside is possible. The established NAICS code is 541690 Other Scientific and Technical Consulting Services. The U.S. Small Business Administration establishes a size standard for 541690 at $16,500,000 or less.
BACKGROUND INFORMATION AND OBJECTIVE:
The National Institutes of Health (NIH) is the nation-s leading medical research agency and the primary federal agency whose mission is to seek fundamental knowledge about the nature and behavior of living systems and the application of that knowledge to enhance health, lengthen life, and reduce illness and disability, conducting, supporting and making medical discoveries that improve people-s health and save lives.
The National Institute on Drug Abuse (NIDA) Intramural Research Program (IRP) is part of the NIH who-s mission is to conduct state-of-the-art research on b... - Documents:
If you are registered member, kindly login to view full details of this tender notice:
CLICK HERE TO LOGINTechnical Consulting Services and Data Analysis of Glucagon-Like Peptide-1 (Glp-1) Analogues as a Novel Pharmacotherapeutic Approach for Alcohol Use Disorder (Aud) - USA Tender
The HEALTH AND HUMAN SERVICES, DEPARTMENT OF, a Government sector organization in USA, has announced a new tender for Technical Consulting Services and Data Analysis of Glucagon-Like Peptide-1 (Glp-1) Analogues as a Novel Pharmacotherapeutic Approach for Alcohol Use Disorder (Aud). This tender is published on USARFP under UST Ref No: 86493632 and is categorized as a Tender. Interested and eligible suppliers are invited to participate by reviewing the tender documents and submitting their bids before the deadline on 2023-08-01.
The estimated tender value is Refer Document, and full details, including technical specifications and submission requirements, are provided in the official tender documents. Ensure all submissions meet the criteria outlined to be considered for evaluation.
